Proc Natl Acad Sci USA 2007,104(10):4136–4141.PubMedCrossRef 18. Vinogradov E, Perry MB, Conlan Enzalutamide manufacturer JW: Structural analysis of learn more Francisella tularensis lipopolysaccharide. Eur J Biochem 2002,269(24):6112–6118.PubMedCrossRef 19. Phillips NJ, Schilling B, McLendon MK, Apicella MA, Gibson BW: Novel

modification of lipid A of Francisella tularensis . Infect Immun 2004,72(9):5340–5348.PubMedCrossRef 20. Kanistanon D, Hajjar AM, Pelletier MR, Gallagher LA, Kalhorn T, Shaffer SA, Goodlett DR, Rohmer L, Brittnacher MJ, Skerrett SJ, et al.: A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog 2008,4(2):e24.PubMedCrossRef 21. Bosio CM, Bielefeldt-Ohmann H, Belisle JT: Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 2007,178(7):4538–4547.PubMed 22. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH: Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 2008,76(12):5843–5852.PubMedCrossRef 23. Mares CA, Ojeda SS, Li Q, Morris EG, Coalson JJ, Teale JM:

Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections. Exp Gerontol 2010,45(2):91–96.PubMedCrossRef 24. Malik M, Bakshi DNA Damage inhibitor CS, McCabe K, Catlett SV, Shah A, Singh R, Jackson PL, Gaggar A, Metzger DW, Melendez JA, et al.: Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis . J Immunol 2007,178(2):1013–1020.PubMed 25. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM: Initial delay in the immune response to Tenoxicam Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 2008,76(7):3001–3010.PubMedCrossRef 26. Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW: Humoral and

cell-mediated immunity to the intracellular pathogen Francisella tularensis . Immunol Rev 2008, 225:244–255.PubMedCrossRef 27. Chang HY, Lee JH, Deng WL, Fu TF, Peng HL: Virulence and outer membrane properties of a galU mutant of Klebsiella pneumoniae CG43. Microb Pathog 1996,20(5):255–261.PubMedCrossRef 28. Choudhury B, Carlson RW, Goldberg JB: The structure of the lipopolysaccharide from a galU mutant of Pseudomonas aeruginosa serogroup-O11. Carbohydr Res 2005,340(18):2761–2772.PubMedCrossRef 29. Genevaux P, Bauda P, DuBow MS, Oudega B: Identification of Tn10 insertions in the rfaG, rfaP , and galU genes involved in lipopolysaccharide core biosynthesis that affect Escherichia coli adhesion. Arch Microbiol 1999,172(1):1–8.PubMedCrossRef 30.